Ling-Chun Chen, Ying-Chen Chen, Chia-Yu Su, Chung-Shu Hong, Hsiu-O Ho, Ming-Thau Sheu
Index: Int. J. Nanomedicine 11 , 1557-66, (2016)
Full Text: HTML
Quercetin (Que) is known to have biological benefits including an anticancer effect, but low water solubility limits its clinical application. The aim of this study was to develop a lecithin-based mixed polymeric micelle (LMPM) delivery system to improve the solubility and bioavailability of Que. The optimal Que-LMPM, composed of Que, lecithin, Pluronic(®) P123, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy[poly(ethylene glycol)-2000] in a proportion of 3:1:17.5:2.5 (w/w), was prepared by a thin-film method. The average size, polydispersion index, encapsulating efficiency, and drug loading of Que-LMPM were 61.60 ± 5.02 nm, 0.589 ± 0.198, 96.87% ± 9.04%, and 12.18% ± 1.11%, respectively. The solubility of Que in the Que-LMPM system increased to 5.81 mg/mL, compared to that of free Que in water of 0.17-7.7 μg/mL. The Que-LMPM system presented a sustained-release property in vitro. The in vitro cytotoxicity assay showed that the 50% inhibitory concentration values toward MCF-7 breast cancer cells for free Que, blank LMPMs, and Que-LMPMs were >200, >200, and 110 μM, respectively, indicating the nontoxicity of the LMPM carrier, but the LMPM formulation enhanced the cytotoxicity of Que against MCF-7 cells. A cellular uptake assay also confirmed the intake of Que-LMPM by MCF-7 cells. An in vivo pharmacokinetic study demonstrated that Que-LMPMs had higher area under the concentration-time curve and a longer half-life, leading to better bioavailability compared to a free Que injection. Due to their nanosize, core-shell structure, and solubilization potential, LMPMs were successfully developed as a drug delivery system for Que to improve its solubility and bioavailability.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
levallorphan hydrogen tartrate
CAS:71-82-9 |
C19H25NO |
The mu opioid irreversible antagonist beta-funaltrexamine di...
1998-11-01 [Psychopharmacology 140 , 20, (1998)] |
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-tr...
1997-01-01 [Mol. Pharmacol. 51 , 87-96, (1997)] |
Delta opioid modulation of the binding of guanosine-5'-O-(3-...
1997-12-01 [J. Pharmacol. Exp. Ther. 283 , 1276, (1997)] |
Regulation of epithelial cell morphology and functions appro...
2012-01-01 [PLoS ONE 7(4) , e36110, (2012)] |
A one-step electrospray-based technique for modulating morph...
2012-01-01 [Int. J. Nanomedicine 7 , 5129-36, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved